Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Eur J Cancer. 2016 Sep 24;67:152–163. doi: 10.1016/j.ejca.2016.08.007

Figure 1. Association of cyclin A1 expression with early relapse and poor prognosis in ovarian cancer.

Figure 1

(A) Plot of cyclin A1 transcript level versus relapse time of ovarian cancer patient. (B) Plot of cyclin A1 protein level versus relapse time of ovarian cancer patient. (C) Kaplan-Meier plot of overall survival of patients with high or low level of cyclin A1 protein expression. The criterion to separate the patients into high expression and low expression group is described in Materials and Methods. Solid line represents the patients with low cyclin A1 expression, whereas the dotted line represents the patients with high cyclin A1 expression.